Laninamivir
![Favipiravir (JAN*) [Applicant] Toyama Chemical Co., Ltd](http://data.docslib.org/img/264x/8f10e27ee9df44cd1604c5bc1cd2e1a9.webp)
Top View
- Report on the Deliberation Results November 26, 2013 Evaluation And
- Review Laninamivir and Its Prodrug, CS-8958: Long-Acting Neuraminidase Inhibitors for the Treatment of Influenza
- Expert Opinion on Neuraminidase Inhibitors for the Prevention and Treatment of Influenza
- Inhaled Laninamivir Octanoate As Prophylaxis for Influenza in Children
- Can Antiviral Drugs Known Today Are Useful in the Treatment of Novel Corona Virus Or COVID-19?
- Remdesivir from Wikipedia, the Free Encyclopedia
- Pharmacokinetics of Laninamivir After a Single Administration of Its
- Antiviral Drugs – Aspects of Clinical Use and Recent Advances
- Joji Nakayama, Representative Director, Pres
- Peramivir and Laninamivir Susceptibility of Circulating Influenza
- Program and Abstracts International Conference Antiviral Research
- Clinical Use of Approved Influenza Antivirals
- New Treatment Strategies for Influenza Luis Del Carpio-Orantes*
- Antiviral Treatments
- Report on the Deliberation Results August 3, 2010 Evaluation And